| Effect | Decrease |
| Trial Design | Non-controlled trial |
| Trial Length | 2-4 Weeks |
| Number of Subjects | 3 |
| Sex | Both Genders |
| Age Range | 7-12 |
A series of three case studies using ginkgo (EGb-761) at 100mg twice daily over four weeks has noted some slight improvements as assessed by the ABC rating scale, but not by clinician assessment.
